TrialDiabetes/metabolism research and reviews2015

Lixisenatide reduces postprandial hyperglycaemia via gastrostatic and insulinotropic effects.

Reinhard H A Becker et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.